JENNIFER DELGADO: Open Payments
NPI 1013420165 · TAVERNIER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 15 payments from 8 companies in 2025. Trend: 2023 $132 · 2024 $450 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $153 |
| Dexcom, Inc. | 5 | $150 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Astellas Pharma US Inc | 1 | $32 |
| Amgen Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| BETA BIONICS, INC. | 1 | $9 |
Products named: Dexcom G6 Transmitter, ISTURISA, AIRSUPRA, Veozah, JARDIANCE, OTEZLA, iLet Bionic Pancreas.
Industry payments across FL — which companies pay providers there.
